We observed a strong negative association between KDM6A‐mut signature score and other aberrations associated with bladder patients with PD‐L1 responders, and a strong positive correlation with CREBBP‐mut and EP300‐mut scores (Figure 6A). The gene discussed is EP300; the disease is carcinoma.